Product
FDA022-BB05
1 clinical trial
1 indication
Indication
Advanced Solid TumorClinical trial
A Phase 2, Multicenter, Open-Label Study to Assess the Efficacy, Safety, Tolerability and Pharmacokinetics of FDA022-BB05 in Patients With Advanced/Metastatic Solid TumorsStatus: Not yet recruiting, Estimated PCD: 2025-07-31